StockCenter
At the Heart of it
 

Search results for bac

 

Bank of America(BAC Quote) said in a regulatory filing late Monday that the Treasury Department will auction 272 million warrants associated with the government's $45 billion bailout of the bank in 2008.
New plans by EU leaders to control the crisis in Greece generated a tailwind for the bulls; it gave the euro [EUR=X 1.3773 0.0009 (+0.07%) ] a boost against the greenback; putting weak dollar trades back in play.

With the euro moving higher, is it time to bet big that the global commodity trade is back on?
BNP Paribas posted higher fourth-quarter profits that beat market forecasts and France's biggest listed bank struck a relatively confident note despite the economic uncertainty clouding the banking industry.
Symetra Finanacial (SYA), a provider of group health, retirement, life and employee benefits insurance, is expected to go public this week. According to WSJ, this is the company's second attempt at an IPO.
JPMorgan reported deep losses on mortgage and credit card loans in the fourth quarter, dashing hopes that consumer credit is on the mend and sending the bank's shares down 2.1 percent.
Bank of America (BAC) is scheduled to release Q4 earnings this Tuesday January 20th, before the market opens.

Average analyst estimates for the big bank are -$.52/share in EPS and $26.84 billion in Revenue. Twenty-five analysts track the stock with two upward EPS revisions in the last 30 days and six downward EPS revisions in the last 30 days.
Stocks suffered the worst one-day decline of 2010 so far, led by the financial sector, which slid after J.P. Morgan Chase's announcement of weaker-than-expected revenue and a glum outlook.
The Dow Jones Industrial Average(INDU 10,610, -100.90, -0.94%) , which hadn't posted a daily decline of more than 37 points in January before Friday, ended down 100.75 points, or 0.9%, at 10,609.80.
Stocks enjoyed a broad rally Wednesday as an analyst upgrade of Merck spurred the health-care sector higher, while financials benefited from hopes for high profits.
Credit Suisse raised its investment rating on the drugmaker to outperform from neutral and boosted its target price on the stock, saying it has a positive view on the company's pipeline.